| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ian Freckelton Ao Q. Children as voices and images for medicinal cannabis law reform. Monash bioethics review. 2021-11-02. PMID:34719005. |
noting the 'rule of rescue' and the prominence in media campaigns of children in australian and english cases of parental disputation with clinicians about treatment for their children, it reviews whether paediatric epilepsy is a suitable test case for the legalisation of medicinal cannabis. |
2021-11-02 |
2023-08-13 |
Not clear |
| Bruria Ben-Zee. Epilepsy and cannabis: facing reality. Developmental medicine and child neurology. 2021-10-29. PMID:34713904. |
epilepsy and cannabis: facing reality. |
2021-10-29 |
2023-08-13 |
Not clear |
| Paula Schaiquevich, Natalia Riva, Cecilia Maldonado, Marta Vázquez, Paulo Cáceres-Guid. Clinical pharmacology of cannabidiol in refractory epilepsy. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. vol 44. issue 5. 2021-10-25. PMID:32853128. |
clinical pharmacology of cannabidiol in refractory epilepsy. |
2021-10-25 |
2023-08-13 |
Not clear |
| José Carlos Pastrana-Trejo, Fátima Duarte-Aké, Rosa Us-Camas, Clelia De-la-Peña, Linda Parker, Roger G Pertwee, Eric Murillo-Rodrígue. Effects on the Post-translational Modification of H3K4Me3, H3K9ac, H3K9Me2, H3K27Me3, and H3K36Me2 Levels in Cerebral Cortex, Hypothalamus and Pons of Rats after a Systemic Administration of Cannabidiol: A Preliminary Study. Central nervous system agents in medicinal chemistry. vol 21. issue 2. 2021-10-25. PMID:32972354. |
cannabidiol (cbd), a non-psychotropic constituent of cannabis sativa, has shown therapeutic promises by modulating several pathological conditions, including pain, epilepsy autism, among others. |
2021-10-25 |
2023-08-13 |
rat |
| Sebastian Jugl, Aimalohi Okpeku, Brianna Costales, Earl J Morris, Golnoosh Alipour-Haris, Juan M Hincapie-Castillo, Nichole E Stetten, Ruba Sajdeya, Shailina Keshwani, Verlin Joseph, Yahan Zhang, Yun Shen, Lauren Adkins, Almut G Winterstein, Amie Goodi. A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019. Medical cannabis and cannabinoids. vol 4. issue 1. 2021-10-23. PMID:34676348. |
few high-quality systematic reviews were available for most conditions, with the exceptions of ms (9 of 9 graded moderate/high quality; evidence for 2/9 indicating cannabis improved outcomes; evidence for 7/9 indicating cannabis inconclusive), epilepsy (3 of 4 graded moderate/high quality; 3 indicating cannabis improved outcomes; 1 indicating cannabis inconclusive), and chronic noncancer pain (12 of 13 graded moderate/high quality; evidence for 7/13 indicating cannabis improved outcomes; evidence from 6/7 indicating cannabis inconclusive). |
2021-10-23 |
2023-08-13 |
human |
| Valentina Franco, Meir Bialer, Emilio Perucc. Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research. Neuropharmacology. vol 185. 2021-10-21. PMID:33347884. |
cannabidiol in the treatment of epilepsy: current evidence and perspectives for further research. |
2021-10-21 |
2023-08-13 |
Not clear |
| Sandip Patel, Reid Grinspoon, Bradley Fleming, Lauren A Skirvin, Christina Wade, Emma Wolper, Patricia L Bruno, Elizabeth A Thiel. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy. Epilepsia. vol 62. issue 7. 2021-10-15. PMID:34050682. |
the long-term efficacy of cannabidiol in the treatment of refractory epilepsy. |
2021-10-15 |
2023-08-13 |
Not clear |
| Sandip Patel, Reid Grinspoon, Bradley Fleming, Lauren A Skirvin, Christina Wade, Emma Wolper, Patricia L Bruno, Elizabeth A Thiel. The long-term efficacy of cannabidiol in the treatment of refractory epilepsy. Epilepsia. vol 62. issue 7. 2021-10-15. PMID:34050682. |
cannabidiol (cbd) has been shown to reduce seizures among patients with refractory epilepsies of various etiologies in recent clinical trials and an expanded access program (eap). |
2021-10-15 |
2023-08-13 |
Not clear |
| Ifrah Zawar, Linfa Franic, Prakash Kotagal, Elia Pestana Knigh. Exacerbation of eyelid myoclonia in patients with epilepsy and eyelid myoclonia receiving cannabidiol. Epileptic disorders : international epilepsy journal with videotape. 2021-10-13. PMID:34642157. |
exacerbation of eyelid myoclonia in patients with epilepsy and eyelid myoclonia receiving cannabidiol. |
2021-10-13 |
2023-08-13 |
Not clear |
| Magda Nowicki, Sandrine Bourgeois-Tardif, Patrick L Diaz, Francois Olivier Hebert, Nathalie T Sanon, Pierre-Olivier Champagne, Philippe Major, Erick Sell, Jonathan Bitton, Evan Lewis, Alexander G Wei. Potential Benefit of Add-on Δ9-Tetrahydrocannabinol in Pediatric Drug-Resistant Epilepsy: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2021-09-22. PMID:34183079. |
we present five cases of pediatric drug-resistant epilepsy (dre) that failed management using high cannabidiol (cbd) doses, but had significant reduction in seizure frequency with reintroduction or increasing doses of tetrahydrocannabinol (thc). |
2021-09-22 |
2023-08-13 |
Not clear |
| George Sam Wang, David W A Bourne, Jost Klawitter, Cristina Sempio, Kevin Chapman, Kelly Knupp, Michael F Wempe, Laura Borgelt, Uwe Christians, Jan Leonard, Kennon Heard, Lalit Baja. Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with Epilepsy. Clinical pharmacokinetics. vol 59. issue 8. 2021-09-20. PMID:32048179. |
disposition of oral cannabidiol-rich cannabis extracts in children with epilepsy. |
2021-09-20 |
2023-08-13 |
Not clear |
| George Sam Wang, David W A Bourne, Jost Klawitter, Cristina Sempio, Kevin Chapman, Kelly Knupp, Michael F Wempe, Laura Borgelt, Uwe Christians, Jan Leonard, Kennon Heard, Lalit Baja. Disposition of Oral Cannabidiol-Rich Cannabis Extracts in Children with Epilepsy. Clinical pharmacokinetics. vol 59. issue 8. 2021-09-20. PMID:32048179. |
the objective of this study was to determine the disposition of oral cannabidiol cannabis extracts and drug interactions in children with pediatric epilepsy. |
2021-09-20 |
2023-08-13 |
Not clear |
| Marta Karaźniewicz-Łada, Anna K Główka, Aniceta A Mikulska, Franciszek K Główk. Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. International journal of molecular sciences. vol 22. issue 17. 2021-09-17. PMID:34502487. |
cannabidiol (cbd) is increasingly used to treat epilepsy. |
2021-09-17 |
2023-08-13 |
Not clear |
| Lyndsey L Anderson, Peter T Doohan, Lachlan Oldfield, Richard C Kevin, Jonathon C Arnold, Maximus Berger, G Paul Amminger, Iain S McGrego. Citalopram and Cannabidiol: In Vitro and In Vivo Evidence of Pharmacokinetic Interactions Relevant to the Treatment of Anxiety Disorders in Young People. Journal of clinical psychopharmacology. vol 41. issue 5. 2021-09-15. PMID:34121064. |
cannabidiol has well-described inhibitory action on cytochrome p450 (cyp450) drug-metabolizing enzymes and significant drug-drug interactions (ddis) between cbd and various anticonvulsant medications (eg, clobazam) have been described in the treatment of epilepsy. |
2021-09-15 |
2023-08-13 |
human |
| Leslie Grayson, Steve Ampah, Kathleen Hernando, Pongkiat Kankirawatana, Tyler Gaston, Gary Cutter, Jerzy P Szaflarski, Elizabeth Martina Bebi. Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy. Epilepsy & behavior : E&B. vol 122. 2021-09-14. PMID:34273739. |
longitudinal impact of cannabidiol on eeg measures in subjects with treatment-resistant epilepsy. |
2021-09-14 |
2023-08-13 |
human |
| Justin C Strickland, Heather Jackson, Nicolas J Schlienz, Jay A Salpekar, Erin L Martin, Joel Munson, Marcel O Bonn-Miller, Ryan Vandre. Cross-sectional and longitudinal evaluation of cannabidiol (CBD) product use and health among people with epilepsy. Epilepsy & behavior : E&B. vol 122. 2021-09-14. PMID:34311183. |
cross-sectional and longitudinal evaluation of cannabidiol (cbd) product use and health among people with epilepsy. |
2021-09-14 |
2023-08-13 |
human |
| Martin Kirkpatrick, Finbar O'callagha. Epilepsy and cannabis: so near, yet so far. Developmental medicine and child neurology. 2021-09-09. PMID:34498262. |
epilepsy and cannabis: so near, yet so far. |
2021-09-09 |
2023-08-13 |
Not clear |
| Martin Kirkpatrick, Finbar O'callagha. Epilepsy and cannabis: so near, yet so far. Developmental medicine and child neurology. 2021-09-09. PMID:34498262. |
subsequently, a pure cannabidiol (cbd) product has been licensed for two epilepsy syndromes. |
2021-09-09 |
2023-08-13 |
Not clear |
| Shimrit Uliel-Sibony, Moran Hausman-Kedem, Aviva Fattal-Valevski, Uri Krame. Cannabidiol-enriched oil in children and adults with treatment-resistant epilepsy-does tolerance exist? Brain & development. vol 43. issue 1. 2021-08-31. PMID:32713661. |
to evaluate the long-term effectiveness of cannabidiol (cbd)-enriched oil for the treatment of refractory epilepsy and to assess the development of tolerance to its anti-seizure effect. |
2021-08-31 |
2023-08-13 |
Not clear |
| Elisa J Sob. Cultural conformity and cannabis care in the wake of intractable pediatric epilepsy. Anthropology & medicine. vol 28. issue 2. 2021-08-19. PMID:34075822. |
cultural conformity and cannabis care in the wake of intractable pediatric epilepsy. |
2021-08-19 |
2023-08-13 |
Not clear |